Article

Atrioesophageal Fistula After Cryoballoon Pulmonary Vein Isolation.

Department of Medicine-Cardiology, University Hospital of Bonn, Bonn, Germany.
Journal of Cardiovascular Electrophysiology (Impact Factor: 3.48). 04/2012; DOI: 10.1111/j.1540-8167.2012.02324.x
Source: PubMed

ABSTRACT Atrioesophageal Fistula After Cryoballoon PV Isolation.  The risk of atrioesophageal fistula after cryoballoon pulmonary vein isolation is thought to be much lower than after radiofrequency ablation, seeing that no data exist on this complication so far. We report for the first time on the occurrence of an atrioesophageal fistula 4 weeks after cryoballoon ablation at the site of the left inferior pulmonary vein. We suggest that even when using cryothermal ablation technique, an imaging modality to assess the proximity of esophagus and left atrium should be routinely performed to avoid this fatal complication. (J Cardiovasc Electrophysiol, Vol. pp. 1-4).

0 Bookmarks
 · 
93 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although atrioesophageal fistula formation (AEF) is a well known, albeit rare, catastrophic complication of atrial fibrillation radiofrequency ablation procedures, there is less data regarding this complication using the cryoballon technique. We report on three cases of AEF as a complication of cryoballoon pulmonary vein isolation at three different institutions with two different generations of cryoballoons.This article is protected by copyright. All rights reserved.
    Journal of Cardiovascular Electrophysiology 04/2014; · 3.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Catheter ablation of atrial flutter and fibrillation (AFL and AF) has typically been performed with radiofrequency energy. Cryoablation has recently been used for AF and AFL, but its success has been limited by the nadir temperature achievable using nitrous oxide as a refrigerant. In this study, a novel approach allowing for use of a liquid refrigerant capable of achieving lower nadir temperatures was tested in a canine model with cavo-tricuspid isthmus (CTI) and left atrial (LA) ablation. In six dogs, under general anesthesia, standard catheters were placed in the coronary sinus and right ventricular apex, and the CryoMedix cryoablation catheter (CAC) in the right (CTI) and left atrium (for ablation, across the LA roof, mitral isthmus, and LA septum). Double-freezes up to 2 min each were performed, with a 30-s thaw cycle between freezes. Ablated areas were subsequently grossly inspected and photographed and tissues fixed in formalin for histologic analysis to determine if the lesions were contiguous and transmural. In all animals, long linear (from 4-8 cm) transmural atrial lesions were observed on gross and histological examination in the left atrial roof, septum and mitral isthmus, and across the cavo-trisucpid isthmus. In all animals, bi-directional cavo-tricuspid isthmus block was observed after ablation, during pacing from the coronary sinus ostium and low lateral right atrium, respectively. Up to 50 % thickness lesions were observed in the right ventricle below the tricuspid valve in all animals. There were no acute complications noted in any animals. The CAC system produces extremely negative freezing temperatures, significantly lower than those reported for nitrous oxide based systems. The CTI was easily ablated with the CAC system, producing bi-directional conduction block, suggesting a potential role for the system in the treatment of isthmus-dependent atrial flutter. Transmural LA lesions were also produced with the CAC system, suggesting a potential role in treating AF.
    Journal of Interventional Cardiac Electrophysiology 11/2013; · 1.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Atrial fibrillation (AF) is the most common symptomatic and sustained cardiac arrhythmia. It affects approximately 2–3 million people in the USA alone with an increased incidence and prevalence worldwide. It is associated, in addition to worsening quality of life, with increased morbidity and mortality especially in poorly controlled AF, affecting mostly those older than 65 years of age. Radiofrequency ablation was found to be a good strategy for focal isolation of pulmonary veins triggering from the vulnerable atrial substrate but is a time-consuming procedure and carries the risk of multiple complications like tamponade which could be fatal, atrioesophageal fistula and local thrombus formation at the site of ablation. Cryoballoon ablation with pulmonary vein isolation has emerged in the past few years as a breakthrough novel technology for the treatment of drug-refractory AF. It is a relatively simple alternative for point-by-point radiofrequency ablation of paroxysmal AF and is associated with fewer incidences of fatal complications such as cardiac perforation. As experience with this new tool accumulates, the field faces new challenges in the form of rare compilations including gastroparesis, phrenic nerve palsy, atrioesophageal fistula, pulmonary vein stenosis, thromboembolism pericardial effusion, and tamponade.
    Expert Review of Cardiovascular Therapy 08/2014;

Florian Stoeckigt